KEI Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 22, 2025, 4:13 am

Competitors of KEI Industries Ltd

All Competitor Stocks of KEI Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:25 pm

Below is a detailed analysis of the quarterly data for KEI Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,590.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,915.00 Cr. (Mar 2025) to 2,590.00 Cr., marking a decrease of 325.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,332.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,614.00 Cr. (Mar 2025) to 2,332.00 Cr., marking a decrease of 282.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 258.00 Cr.. The value appears to be declining and may need further review. It has decreased from 301.00 Cr. (Mar 2025) to 258.00 Cr., marking a decrease of 43.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00%.
• For Other Income, as of Jun 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 263.00 Cr.. The value appears to be declining and may need further review. It has decreased from 305.00 Cr. (Mar 2025) to 263.00 Cr., marking a decrease of 42.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 227.00 Cr. (Mar 2025) to 196.00 Cr., marking a decrease of 31.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 20.49. The value appears to be declining and may need further review. It has decreased from 23.71 (Mar 2025) to 20.49, marking a decrease of 3.22.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:00 am

Growth

Last Updated: September 5, 2025, 9:00 am

Balance Sheet

Last Updated: May 13, 2025, 3:14 pm

Below is a detailed analysis of the balance sheet data for KEI Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 5,767.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,130.00 Cr. (Mar 2024) to 5,767.00 Cr., marking an increase of 2,637.00 Cr..
• For Borrowings, as of Mar 2025, the value is 217.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 166.00 Cr. (Mar 2024) to 217.00 Cr., marking an increase of 51.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,232.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,342.00 Cr. (Mar 2024) to 1,232.00 Cr., marking a decrease of 110.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,235.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,656.00 Cr. (Mar 2024) to 7,235.00 Cr., marking an increase of 2,579.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 770.00 Cr. (Mar 2024) to 993.00 Cr., marking an increase of 223.00 Cr..
• For CWIP, as of Mar 2025, the value is 385.00 Cr.. The value appears strong and on an upward trend. It has increased from 121.00 Cr. (Mar 2024) to 385.00 Cr., marking an increase of 264.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,854.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,764.00 Cr. (Mar 2024) to 5,854.00 Cr., marking an increase of 2,090.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,235.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,656.00 Cr. (Mar 2024) to 7,235.00 Cr., marking an increase of 2,579.00 Cr..

Notably, the Reserves (5,767.00 Cr.) exceed the Borrowings (217.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for KEI Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 21.80. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 21.80, marking an increase of 8.31.
• For Diluted EPS (Rs.), as of Mar 25, the value is 21.80. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 21.80, marking an increase of 8.31.
• For Cash EPS (Rs.), as of Mar 25, the value is 28.34. This value is within the healthy range. It has increased from 20.70 (Mar 24) to 28.34, marking an increase of 7.64.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 200.88. It has increased from 159.30 (Mar 24) to 200.88, marking an increase of 41.58.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 200.88. It has increased from 159.30 (Mar 24) to 200.88, marking an increase of 41.58.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 820.69. It has increased from 774.57 (Mar 24) to 820.69, marking an increase of 46.12.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 59.16. This value is within the healthy range. It has increased from 49.28 (Mar 24) to 59.16, marking an increase of 9.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 52.26. This value is within the healthy range. It has increased from 42.07 (Mar 24) to 52.26, marking an increase of 10.19.
• For PBT / Share (Rs.), as of Mar 25, the value is 27.33. This value is within the healthy range. It has increased from 16.59 (Mar 24) to 27.33, marking an increase of 10.74.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 21.44. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 21.44, marking an increase of 7.95.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 21.44. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 21.44, marking an increase of 7.95.
• For PBDIT Margin (%), as of Mar 25, the value is 7.20. This value is below the healthy minimum of 10. It has increased from 6.36 (Mar 24) to 7.20, marking an increase of 0.84.
• For PBIT Margin (%), as of Mar 25, the value is 6.36. This value is below the healthy minimum of 10. It has increased from 5.43 (Mar 24) to 6.36, marking an increase of 0.93.
• For PBT Margin (%), as of Mar 25, the value is 3.32. This value is below the healthy minimum of 10. It has increased from 2.14 (Mar 24) to 3.32, marking an increase of 1.18.
• For Net Profit Margin (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 5. It has increased from 1.74 (Mar 24) to 2.61, marking an increase of 0.87.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 8. It has increased from 1.74 (Mar 24) to 2.61, marking an increase of 0.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.67. This value is below the healthy minimum of 15. It has increased from 8.46 (Mar 24) to 10.67, marking an increase of 2.21.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.36. This value is within the healthy range. It has decreased from 23.92 (Mar 24) to 23.36, marking a decrease of 0.56.
• For Return On Assets (%), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.57, marking an increase of 0.75.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.69. This value is within the healthy range. It has decreased from 0.93 (Mar 24) to 0.69, marking a decrease of 0.24.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. There is no change compared to the previous period (Mar 24) which recorded 1.06.
• For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has increased from 1.11 (Mar 24) to 1.19, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 1.12, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 18.56. This value exceeds the healthy maximum of 8. It has increased from 7.16 (Mar 24) to 18.56, marking an increase of 11.40.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.01. This value is below the healthy minimum of 20. It has decreased from 22.23 (Mar 24) to 18.01, marking a decrease of 4.22.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.63. This value is below the healthy minimum of 20. It has decreased from 14.49 (Mar 24) to 13.63, marking a decrease of 0.86.
• For Earning Retention Ratio (%), as of Mar 25, the value is 81.99. This value exceeds the healthy maximum of 70. It has increased from 77.77 (Mar 24) to 81.99, marking an increase of 4.22.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.37. This value exceeds the healthy maximum of 70. It has increased from 85.51 (Mar 24) to 86.37, marking an increase of 0.86.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 3. It has increased from 1.93 (Mar 24) to 2.37, marking an increase of 0.44.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 3. It has increased from 1.53 (Mar 24) to 1.86, marking an increase of 0.33.
• For Enterprise Value (Cr.), as of Mar 25, the value is 23,876.65. It has increased from 21,380.49 (Mar 24) to 23,876.65, marking an increase of 2,496.16.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has increased from 1.07 (Mar 24) to 1.09, marking an increase of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 15.16. This value exceeds the healthy maximum of 15. It has decreased from 16.88 (Mar 24) to 15.16, marking a decrease of 1.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.89 (Mar 24) to 0.95, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 81.98. This value exceeds the healthy maximum of 70. It has increased from 77.76 (Mar 24) to 81.98, marking an increase of 4.22.
• For Price / BV (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 4.36 (Mar 24) to 3.90, marking a decrease of 0.46.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.89 (Mar 24) to 0.95, marking an increase of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness